Track topics on Twitter Track topics that are important to you
The post UK’s NICE rejects Roche’s Tecentriq for triple negative breast cancer appeared first on Pharmaceutical Technology.
Original Article: UK’s NICE rejects Roche’s Tecentriq for triple negative breast cancerNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...